Brief: Iveric Bio Reaffirmation Of Financial Guidance For FY22
March 25 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO INC- REAFFIRMATION OF FINANCIAL GUIDANCE FOR FY
2022
* IVERIC BIO - ESTIMATES CASH AND AVAILABLE-FOR-SALE
SECURITIES
WILL BE SUFFICIENT TO FUND PLANNED CAPEX NEEDS, OPERATING
EXPENSES THROUGH AT LEAST MID-2024
* IVERIC BIO INC- NO PLANS FOR EQUITY FINANCING PRIOR TO
GATHER2
TOPLINE DATA
Further company coverage: ISEE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini